Evidence map›Paper›PMID 28241168›Full record

Observational studyJAMA neurology2017

Association of Depression and Treated Depression With Epilepsy and Seizure Outcomes: A Multicohort Analysis.

Colin B Josephson, Mark Lowerison, Isabelle Vallerand, Tolulope T Sajobi, Scott Patten, Nathalie Jette, Samuel Wiebe

Open access · greenAbstract readObservational Study
In one paragraph

Observational study in JAMA neurology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 86 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
86citing papers in PubMed, 2 pooled it
10.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

86 citing papers in PubMed, 2 syntheses or guidelines pooled it, 186 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Modelling risk factors for depressive symptoms in seizure disorders.Therapeutic advances in neurological disorders · 2026
    Article
  11. Article
  12. Article
  13. Comorbid depression is associated with non-routine discharge following treatment of unruptured cerebral aneurysms.Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia · 2025
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Intracranial substrates of meditation-induced neuromodulation in the amygdala and hippocampus.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  19. Review
  20. Observational

26 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Colin B JosephsonDepartment of Clinical Neurosciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada2Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Alberta, Canada3Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada4O'Brien Institute of Public Health, University of Calgary, Calgary, Alberta, Canada.
Mark LowerisonDepartment of Community Health Sciences, Cumming School of Medicine, University of Calgary, Alberta, Canada5Clinical Research Unit, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Isabelle VallerandDepartment of Community Health Sciences, Cumming School of Medicine, University of Calgary, Alberta, Canada.
Tolulope T SajobiDepartment of Clinical Neurosciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada2Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Alberta, Canada3Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada4O'Brien Institute of Public Health, University of Calgary, Calgary, Alberta, Canada.
Scott PattenDepartment of Community Health Sciences, Cumming School of Medicine, University of Calgary, Alberta, Canada3Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada4O'Brien Institute of Public Health, University of Calgary, Calgary, Alberta, Canada6Department of Psychiatry, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Nathalie JetteDepartment of Clinical Neurosciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada2Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Alberta, Canada3Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada4O'Brien Institute of Public Health, University of Calgary, Calgary, Alberta, Canada.
Samuel WiebeDepartment of Clinical Neurosciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada2Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Alberta, Canada3Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada4O'Brien Institute of Public Health, University of Calgary, Calgary, Alberta, Canada5Clinical Research Unit, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
University of Calgary · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Importance: A bidirectional relationship exists between epilepsy and depression. However, any putative biological gradient between depression severity and the risk of epilepsy, and the degree to which depression mediates the influence of independent risk factors for epilepsy, has yet to be examined. Objective: To determine the effect of depression on the risk of epilepsy and seizure outcomes. Design, Setting, and Participants: An observational study of a population-based primary care cohort (all patients free of prevalent depression and epilepsy at 18-90 years of age who were active after the Acceptable Mortality Reporting date in The Health Improvement Network database) and a prospectively collected tertiary care cohort (all patients whose data were prospectively collected from the Calgary Comprehensive Epilepsy Programme). The analyses were performed on March 16, 2016. Main Outcome and Measures: The hazard of developing epilepsy after incident depression and vice versa was calculated. In addition, a mediation analysis of the effect of depression on risk factors for epilepsy and the odds of seizure freedom stratified by the presence of depression were performed. Results: We identified 10 595 709 patients in The Health Improvement Network of whom 229 164 (2.2%) developed depression and 97 177 (0.9%) developed epilepsy. The median age was 44 years (interquartile range, 32-58 years) for those with depression and 56 years (interquartile range, 43-71 years) for those with epilepsy. Significantly more patients with depression (144 373 [63%] were women, and 84 791 [37%] were men; P < .001) or epilepsy (54 419 [56%] were women, and 42 758 [44%] were men; P < .001) were female. Incident epilepsy was associated with an increased hazard of developing depression (hazard ratio [HR], 2.04 [95% CI, 1.97-2.09]; P < .001), and incident depression was associated with an increased hazard of developing epilepsy (HR, 2.55 [95% CI, 2.49-2.60]; P < .001) There was an incremental hazard according to depression treatment type with lowest risk for those receiving counselling alone (HR, 1.84 [95% CI, 1.30-2.59]; P < .001), an intermediate risk for those receiving antidepressants alone (HR, 3.43 [95% CI, 3.37-3.47]; P < .001), and the highest risk for those receiving both (HR, 9.85 [95% CI, 5.74-16.90]; P < .001). Furthermore, depression mediated the relationship between sex, social deprivation, and Charlson Comorbidity Index with incident epilepsy, accounting for 4.6%, 7.1%, and 20.6% of the total effects of these explanatory variables, respectively. In the Comprehensive Epilepsy Programme, the odds of failing to achieve 1-year seizure freedom were significantly higher for those with depression or treated depression. Conclusions and Relevance: Common underlying pathophysiological mechanisms may explain the risk of developing epilepsy following incident depression. Treated depression is associated with worse epilepsy outcomes, suggesting that this may be a surrogate for more severe depression and that severity of depression is associated with severity of epilepsy.

Indexed as

Severity of Illness IndexAdultAgedAntidepressive AgentsCohort StudiesComorbidityCounselingDepressive DisorderEpilepsyFemaleHumansMaleMiddle AgedOutcome Assessment, Health CareRisk FactorsUnited KingdomAntidepressive Agents

Identifiers

PMID28241168
PMCPMC5822203
OpenAlexW2593525832

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.